-

Owlet to Participate in TD Cowen's 45th Annual Health Care Conference

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today that it will participate in TD Cowen's 45th Annual Health Care Conference on March 5, 2025 at the Boston Marriott Copley Place. Kurt Workman, Owlet’s Chief Executive Officer and Co-Founder, Jonathan Harris, President and Chief Revenue Officer, and Amanda Twede-Crawford, Chief Financial Officer, are scheduled to engage in a fireside chat on Wednesday, March 5, 2025, at 9:50 a.m. ET.

A link to the live webcast of the fireside chat will be available on the Owlet Investor Relations website, investors.owletcare.com. A replay of the webcast will also be available on Owlet’s Investor Relations website.

About Owlet, Inc.

Owlet’s digital health infant monitoring platform is transforming the journey of parenting. The Company (NYSE: OWLT), a small-cap healthcare growth equity, offers FDA-authorized medical and consumer pediatric wearables and an integrated HD visual and audio camera that provide real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children.

Since 2012, over two million parents worldwide have used Owlet’s platform contributing to one of the largest collections of consumer infant health and sleep data. The Company continues to develop software and digital data solutions to bridge the current healthcare gap between hospital and home and bring new insights to parents and caregivers globally. Owlet believes that every child deserves to live a long, happy, and healthy life.

To learn more, visit www.owletcare.com.

Contacts

Investor Relations:
ir@owletcare.com

Media:
pr@owletcare.com

Owlet, Inc.

NYSE:OWLT

Release Versions
$Cashtags

Contacts

Investor Relations:
ir@owletcare.com

Media:
pr@owletcare.com

Social Media Profiles
More News From Owlet, Inc.

Owlet Announces New DME Partnership With 1 Natural Way to Expand Insurance-Supported Access to BabySat® Infant Pulse Oximeter

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new durable medical equipment (DME) partnership with 1 Natural Way, a leading national mom-and-baby-focused DME provider. Families nationwide can now access Owlet’s FDA-cleared prescription pulse oximeter, BabySat, through insurance-supported pathways on 1NaturalWay.com. Expanding Owlet’s DME Reach for Families Who Need It Most 1 Natural Way offers a nation...

Owlet Launches Owlet360™ in the UK and Ireland, Bringing Data-Driven Reassurance to More Families

LONDON--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the UK and Ireland launch of Owlet360™, a new subscription service designed to give parents a deeper, personalized understanding of their baby’s sleep and daily trends. Built for families using medically-certified Dream Sock® and Dream Sight™ or Owlet Cam® 2, Owlet360 leverages Owlet’s unique infant dataset to deliver actionable insights and context, helping pare...

Owlet Launches TGA-Approved Dream Sock™ in Australia & New Zealand, Expanding International Footprint and Bringing Trusted Pediatric Health Monitoring to More Families Worldwide

SYDNEY--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ is now available for families across Australia and New Zealand. Dream Sock recently received approval from Australia’s Therapeutic Goods Administration (TGA), meeting rigorous medical device standards in the region. With this milestone achieved, families can now purchase Dream Sock through Owlet’s local website and select retail partners. “Bringi...
Back to Newsroom